Akihiro Taguchi

982 total citations
57 papers, 619 citations indexed

About

Akihiro Taguchi is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Akihiro Taguchi has authored 57 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 15 papers in Organic Chemistry and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Akihiro Taguchi's work include Chemical Synthesis and Analysis (22 papers), Muscle Physiology and Disorders (13 papers) and Click Chemistry and Applications (9 papers). Akihiro Taguchi is often cited by papers focused on Chemical Synthesis and Analysis (22 papers), Muscle Physiology and Disorders (13 papers) and Click Chemistry and Applications (9 papers). Akihiro Taguchi collaborates with scholars based in Japan, United States and Canada. Akihiro Taguchi's co-authors include Yoshio Hayashi, Kentaro Takayama, Fumika Yakushiji, Atsuhiko Taniguchi, Keisuke Hamada, Thanigaimalai Pillaiyar, Sho Konno, Takehito Yamamoto, Arne Schön and Kenichi Akaji and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Akihiro Taguchi

55 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akihiro Taguchi Japan 16 428 219 86 82 69 57 619
Shinichi Imamura Japan 19 380 0.9× 285 1.3× 68 0.8× 61 0.7× 63 0.9× 30 788
Justin K. Murray United States 16 793 1.9× 314 1.4× 41 0.5× 73 0.9× 12 0.2× 24 939
Eun Jung Ko South Korea 13 261 0.6× 210 1.0× 20 0.2× 57 0.7× 17 0.2× 24 631
Aibin Shi United States 10 555 1.3× 162 0.7× 32 0.4× 19 0.2× 13 0.2× 17 803
Virneliz Fernández-Vega United States 15 460 1.1× 159 0.7× 29 0.3× 28 0.3× 87 1.3× 35 738
Jianbo Liu China 13 159 0.4× 89 0.4× 16 0.2× 41 0.5× 61 0.9× 43 423
Christopher Chidley United States 8 363 0.8× 85 0.4× 24 0.3× 18 0.2× 79 1.1× 10 538
Edward G. McIver United Kingdom 15 357 0.8× 276 1.3× 13 0.2× 49 0.6× 28 0.4× 17 843
Deborah H. Slee United States 13 281 0.7× 162 0.7× 15 0.2× 19 0.2× 28 0.4× 18 554
Michael Thormann Germany 13 451 1.1× 173 0.8× 21 0.2× 68 0.8× 8 0.1× 20 664

Countries citing papers authored by Akihiro Taguchi

Since Specialization
Citations

This map shows the geographic impact of Akihiro Taguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Taguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Taguchi more than expected).

Fields of papers citing papers by Akihiro Taguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Taguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Taguchi. The network helps show where Akihiro Taguchi may publish in the future.

Co-authorship network of co-authors of Akihiro Taguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Taguchi. A scholar is included among the top collaborators of Akihiro Taguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Taguchi. Akihiro Taguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taguchi, Akihiro, Ryōichi Yamamoto, Susumu Kuraishi, et al.. (2025). Development of Water‐Soluble 3‐Nitro‐2‐Pyridinesulfenate for Disulfide Bond Formation of Peptide Under Aqueous Conditions. Chemistry - A European Journal. 31(32). e202500855–e202500855.
2.
Taguchi, Akihiro, et al.. (2024). Structure Derivatization of IgG-Binding Peptides and Analysis of Their Secondary Structure by Circular Dichroism Spectroscopy. Chemical and Pharmaceutical Bulletin. 72(9). 831–837. 1 indexed citations
3.
Takayama, Kentaro, Kenji Mori, Yu Sasaki, et al.. (2024). Discovery of a Pentapeptide Antagonist to Human Neuromedin U Receptor 1. ACS Medicinal Chemistry Letters. 15(6). 885–891. 2 indexed citations
4.
Konno, Sho, et al.. (2023). Peptide mixed phosphonates for covalent complex formation with thioesterases in nonribosomal peptide synthetases. Journal of Peptide Science. 30(1). e3532–e3532. 1 indexed citations
5.
Murakami, Hironobu, Yuuta Fujikawa, Masaya Mori, et al.. (2023). Development of a novel fluorogenic assay method for screening inhibitors of bovine leukemia virus protease and identification of mitorubrinic acid as an anti-BLV compound. Bioscience Biotechnology and Biochemistry. 87(9). 946–953. 1 indexed citations
6.
Taguchi, Akihiro, et al.. (2022). Influence of novel readthrough agents on myelin protein zero translation in the peripheral nervous system. Neuropharmacology. 211. 109059–109059. 4 indexed citations
7.
Ninomiya, Akihiro, Koichiro Kako, Yohei Katsuyama, et al.. (2021). Structural Revision of Natural Cyclic Depsipeptide MA026 Established by Total Synthesis and Biosynthetic Gene Cluster Analysis. Angewandte Chemie International Edition. 60(16). 8792–8797. 7 indexed citations
8.
Taguchi, Akihiro, et al.. (2021). Proposal for the binding mode of the 23-mer inhibitory peptide to myostatin. Bioorganic & Medicinal Chemistry. 40. 116181–116181. 2 indexed citations
9.
Takayama, Kentaro, et al.. (2021). Strategic structure–activity relationship study on a follistatin-derived myostatin inhibitory peptide. Bioorganic & Medicinal Chemistry Letters. 46. 128163–128163. 4 indexed citations
10.
Takayama, Kentaro, Kenji Mori, Akiko Tanaka, et al.. (2020). A chemically stable peptide agonist to neuromedin U receptor type 2. Bioorganic & Medicinal Chemistry. 28(10). 115454–115454. 9 indexed citations
11.
Takayama, Kentaro, Takahiro Shimada, Akihiro Taguchi, et al.. (2019). Chain-Shortened Myostatin Inhibitory Peptides Improve Grip Strength in Mice. ACS Medicinal Chemistry Letters. 10(6). 985–990. 13 indexed citations
12.
Takayama, Kentaro, Keisuke Hitachi, Akihiro Taguchi, et al.. (2019). Discovery of a follistatin-derived myostatin inhibitory peptide. Bioorganic & Medicinal Chemistry Letters. 30(3). 126892–126892. 10 indexed citations
13.
Yakushiji, Fumika, et al.. (2017). Click strategy using disodium salts of amino acids improves the water solubility of plinabulin and KPU-300. Bioorganic & Medicinal Chemistry. 25(14). 3623–3630. 10 indexed citations
14.
Taguchi, Akihiro, Keisuke Hamada, & Yoshio Hayashi. (2017). Chemotherapeutics overcoming nonsense mutation-associated genetic diseases: medicinal chemistry of negamycin. The Journal of Antibiotics. 71(2). 205–214. 7 indexed citations
15.
Yakushiji, Fumika, Yamato Kikkawa, Akihiro Taguchi, et al.. (2016). Novel Hybrid Compound of a Plinabulin Prodrug with an IgG Binding Peptide for Generating a Tumor Selective Noncovalent-Type Antibody–Drug Conjugate. Bioconjugate Chemistry. 27(7). 1606–1613. 20 indexed citations
16.
Takayama, Kentaro, Kenji Mori, Akihiro Taguchi, et al.. (2015). Discovery of Potent Hexapeptide Agonists to Human Neuromedin U Receptor 1 and Identification of Their Serum Metabolites. ACS Medicinal Chemistry Letters. 6(3). 302–307. 16 indexed citations
17.
Taguchi, Akihiro, Keisuke Hamada, Masataka Shiozuka, et al.. (2014). Discovery of Natural Products Possessing Selective Eukaryotic Readthrough Activity: 3‐epi‐Deoxynegamycin and Its Leucine Adduct. ChemMedChem. 9(10). 2233–2237. 18 indexed citations
18.
Hayashi, Yoshiki, Takumi Chinen, Kohei Okuyama, et al.. (2014). Development of a New Benzophenone–Diketopiperazine-Type Potent Antimicrotubule Agent Possessing a 2-Pyridine Structure. ACS Medicinal Chemistry Letters. 5(10). 1094–1098. 34 indexed citations
19.
Pillaiyar, Thanigaimalai, Sho Konno, Takehito Yamamoto, et al.. (2013). Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies. European Journal of Medicinal Chemistry. 68. 372–384. 68 indexed citations
20.
Pillaiyar, Thanigaimalai, Sho Konno, Takehito Yamamoto, et al.. (2013). Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study. European Journal of Medicinal Chemistry. 65. 436–447. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026